updates from the phase i/ii bruin study: pirtobrutinib in cll
Published 2 years ago • 124 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
1:51
updates on the phase i/ii bruin study and the role of pirtobrutinib in mcl
-
2:11
latest updates from the phase i/ii bruin study
-
1:55
update on the phase i/ii bruin study
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:32
an update from bellwave-001: nemtabrutinib in cll/sll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
3:53
updates from the german cll study group
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
6:01
we aim to cure - biomea fusion
-
7:50
which aml patients benefit most from venetoclax treatment?
-
1:08
overview of the phase i study with acalabrutinib (acp-196) in cll
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
4:08
phase ib trial of ianalumab plus ibrutinib for cll
-
3:07
barriers to progressing cll treatment in taiwan: treatment access and biomarkers
-
1:37
causes & management of ibrutinib discontinuation in cll
-
1:43
some insights into bruin cll-322: a trial in progress
-
1:18
updates from current cll clinical trials
-
1:26
the impact of comorbidity burden on treatment decisions in cll
-
2:59
clinical trial updates and time-limited therapy in cll
-
1:07
final results of a phase ii study of add-on parsaclisib for pts with mf and suboptimal rux response
-
2:23
significance of eric study in identifying p53 mutants in cll